| |
| |
|
| Insider
Information: |
Brancaccio John P |
| Relationship: |
Director |
| City: |
Bloomfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
135,839 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,909 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
135,839 |
|
|
| Total
Value |
$25,909 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -7.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardiff Oncology Inc |
CRDF |
Director |
2021-03-22 |
12,260 |
|
0 |
Premium* |
|
|
Callisto Pharmaceuticals Inc |
CLSP |
Director |
2013-01-17 |
0 |
2013-01-17 |
0 |
Premium* |
|
|
Synergy Pharmaceuticals Inc (FL) |
SGYP |
Director |
2018-07-04 |
116,571 |
2013-01-17 |
0 |
Premium* |
|
|
Hepion Pharmaceuticals, Inc |
HEPA |
Director |
2020-12-02 |
7,008 |
2014-02-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2021-03-22 |
4 |
B |
$10.95 |
$32,850 |
D/D |
3,000 |
12,260 |
2.39 |
- |
|
| HEPA |
Hepion Pharmaceuticals, I... |
Director |
– • – |
2020-12-02 |
4 |
B |
$1.53 |
$10,710 |
D/D |
7,000 |
7,008 |
2.39 |
% |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2020-05-14 |
4 |
B |
$1.43 |
$10,000 |
D/D |
6,993 |
9,260 |
2.39 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Director |
– • – |
2018-07-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,896) |
116,571 |
0 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Director |
– • – |
2018-07-04 |
4 |
OE |
$0.50 |
$25,012 |
D/D |
50,023 |
130,467 |
0 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2018-06-08 |
4 |
B |
$0.80 |
$8,000 |
D/D |
10,000 |
53,167 |
2.39 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2018-06-08 |
4/A |
B |
$0.80 |
$8,000 |
D/D |
10,000 |
13,598 |
2.39 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Director |
– • – |
2018-04-02 |
4 |
OE |
$0.50 |
$25,000 |
D/D |
50,000 |
76,944 |
0 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2018-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,667 |
43,167 |
0 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2017-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,667 |
26,500 |
0 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Director |
– • – |
2017-05-26 |
4 |
B |
$3.59 |
$23,335 |
D/D |
6,500 |
30,444 |
2.39 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Director |
– • – |
2016-09-19 |
4 |
S |
$5.76 |
$14,504 |
D/D |
(2,518) |
20,444 |
0 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Director |
– • – |
2016-09-19 |
4 |
OE |
$4.28 |
$11,252 |
D/D |
2,518 |
22,962 |
0 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Director |
– • – |
2014-06-03 |
4 |
B |
$4.12 |
$14,420 |
D/D |
3,500 |
23,944 |
2.39 |
- |
|
| HEPA |
Hepion Pharmaceuticals, I... |
Director |
– • – |
2014-03-04 |
4 |
B |
$1.49 |
$6,546 |
D/D |
4,393 |
6,408 |
2.39 |
- |
|
| HEPA |
Hepion Pharmaceuticals, I... |
Director |
– • – |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,015 |
2,015 |
0 |
- |
|
| CLSP |
Callisto Pharmaceuticals ... |
Director |
– • – |
2013-01-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(113,636) |
0 |
0 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Director |
– • – |
2013-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
20,444 |
20,444 |
0 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2012-01-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
83,000 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
